Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A04AA02	GRANI-DENK	G	Granisetron - 3mg/3ml	3mg/3ml	Injectable concentrate for solution	1,679,803 L.L
A04AA02	GRANI-DENK	G	Granisetron - 1mg/ml	1mg/ml	Injectable concentrate for solution	893,655 L.L
A03AB02	GLYCOPYRROLATE	B	Glycopyronium Bromide - 0.2mg/ml	0.2mg/ml	Injectable solution	7,238,185 L.L
D02AX	GLYCERINE	G	Glycerol -		Liquid	163,821 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
H04AA01	GLUCAGEN	BioTech	Glucagon HCl - 1mg	1mg	Injectable powder for solution+diluent	1,343,444 L.L
A10BB12	GLIM	G	Glimepiride - 4mg	4mg	Tablet	628,918 L.L
A10BB12	GLUMYL 4	G	Glimepiride - 4mg	4mg	Tablet	317,403 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 4mg	4mg	Tablet	657,139 L.L
A10BB12	GLIM	G	Glimepiride - 3mg	3mg	Tablet	533,505 L.L
A10BB12	GLUMYL 3	G	Glimepiride - 3mg	3mg	Tablet	511,940 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 3mg	3mg	Tablet	571,133 L.L
A10BB12	GLIM	G	Glimepiride - 2mg	2mg	Tablet	401,809 L.L
A10BB12	GLUMYL 2	G	Glimepiride - 2mg	2mg	Tablet	189,418 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 2mg	2mg	Tablet	403,153 L.L
A10BB12	GLIM	G	Glimepiride - 1mg	1mg	Tablet	302,365 L.L
A10BB12	GLUMYL 1	G	Glimepiride - 1mg	1mg	Tablet	186,858 L.L
A10BB09	GLYZIDE	G	Gliclazide - 80mg	80mg	Tablet	534,849 L.L
A10BB01	GLIBENCLAMIDE	G	Glibenclamide - 5mg	5mg	Tablet, scored	340,440 L.L
A10BB01	GLIBENCLAMIDE	G	Glibenclamide - 5mg	5mg	Tablet	326,362 L.L
L03AX13	GLITAXON	G	Glatiramer acetate - 20mg/ml	20mg/ml	Injectable solution	10,146,988 L.L
C05CX	GINKGO BIOGARAN	G	Ginkgo biloba extract - 40mg	40mg	Tablet, coated	345,368 L.L
C05CX	GINKGO BIOGARAN	G	Ginkgo biloba extract - 40mg	40mg	Tablet, coated	985,037 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 80mg/2ml	80mg/2ml	Injectable solution	721,643 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 80mg/2ml	80mg/2ml	Injectable solution	721,643 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 40mg/2ml	40mg/2ml	Injectable solution	643,701 L.L
J01GB03	GENTAMICINE PANPHARMA	G	Gentamicin (sulfate) - 40mg/2ml	40mg/2ml	Injectable solution	643,701 L.L
L01BC05	GEMTABINE 200	G	Gemcitabine HCl - 200mg	200mg	Injectable lyophilised powder for solution	1,343,843 L.L
L01BC05	GEMTABINE 1000	G	Gemcitabine HCl - 1,000mg	1,000mg	Injectable lyophilised powder for solution	4,882,628 L.L